Literature DB >> 7764337

Characterization of erythropoietin isolated from rat serum: biochemical comparison of rat and human erythropoietins.

M Okano1, H Suga, S Masuda, M Nagao, H Narita, K Ikura, R Sasaki.   

Abstract

We isolated erythropoietin (Epo) from anemic-rat serum with 1.3 x 10(6)-fold purification and 38% recovery using immunoaffinity chromatography. The isolated Epo migrated in SDS polyacrylamide gel with a molecular size of 37 kDa. Biological properties of rat Epo were compared with those of human Epo using target cells of primate and murine origins. When murine cells were used as target cells for assaying Epo, rat Epo stimulated proliferation of the cells with a 50% lower potency than did human Epo. The activity of rat Epo on human cells was only 25% of that of human Epo. Studies of Epo binding to the receptor indicated that rat and human Epos were not distinguishable in binding to murine cells; however, rat Epo bound to the receptor on human cells with an affinity much lower than that of human Epo. Rat Epo was digested with N-glycanase. Complete removal of N-linked sugars converted the native Epo to the deglycosylated form with 18 kDa. The in vitro activity of deglycosylated Epo was 2.5-fold higher than that of the native Epo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7764337     DOI: 10.1271/bbb.57.1882

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Erythropoietin processing in erythropoietic system and central nervous system.

Authors:  M Nagao; S Masuda; M Ueda; R Sasaki
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

2.  Dynamic control of oligosaccharide modification in the mammary gland: linking recombinant human erythropoietin functional analysis of transgenic mouse milk-derived hEPO.

Authors:  Deug-Nam Kwon; Hyuk Song; Jong-Yi Park; So-Young Lee; Seong-Keon Cho; Sung-Jo Kang; Joung Soon Jang; Han Geuk Seo; Jin-Hoi Kim
Journal:  Transgenic Res       Date:  2006-02       Impact factor: 2.788

3.  Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.

Authors:  W Ceelen; T Boterberg; P Smeets; N Van Damme; P Demetter; O Zwaenepoel; L Cesteleyn; P Houtmeyers; M Peeters; P Pattyn
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

4.  A therapeutic vascular conduit to support in vivo cell-secreted therapy.

Authors:  Edward X Han; Hong Qian; Bo Jiang; Maria Figetakis; Natalia Kosyakova; George Tellides; Laura E Niklason; William G Chang
Journal:  NPJ Regen Med       Date:  2021-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.